Snap launches multi-CTA ad format for compliant pharma campaigns

August 17, 2026 · mediapost.com

Ninety-five percent of Snapchat's 971 million global users say they have an active interest in health and wellness topics, according to Snap. The platform is opening that audience to pharma marketers with a new multi-CTA attachment format, which lets brands pair a primary call-to-action with up to three disclaimer links in the same ad. The format is available now on Snap Ads, Story Ads and Commercials, and Snap plans to extend it to Sponsored Snaps by the end of 2026. Small, separate text links appear below the primary unit so users can tap through to safety guides or other required disclosures without leaving their feed. "Every patient, caregiver, and healthcare professional may need different resources depending on where they are in their healthcare journey," Snap said in its announcement.

Rx campaigns on Snapchat can now meet one-click safety disclosure requirements without sending users off-platform, a compliance step that pharma media plans have often struggled to build natively into social feeds. Agencies running pharma accounts gain a format that keeps required disclaimers inside Snap's environment while still reaching a user base Snap positions as highly engaged with health content. The rollout gives media buyers another regulated ad unit to weigh against TV and other channels when planning Rx budgets, particularly as Sponsored Snaps support arrives by the end of 2026.